Clinical Study
Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival
Table 1
Patient characteristics according to the treatment group.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Primary tumor site unknown for one IL-2 patient, **data not available for 4 TIL patients and 2 IL-2 patients, and ***data not available for 1 TIL patient and 1 IL-2 patient. |